News
Vietnam Investment Review on MSN2h
Alphamab s Innovative ADC JSKN022 Accepted for Clinical EvaluationAlphamab Oncology (stock code: 9966.HK) announced that the Investigational New Drug (IND) application for JSKN022, an independently developed innovative bispecific antibody-drug conjugate (ADC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback